Cowell Health has announced a partnership with UK-based AstraZeneca (AZ, NASDAQ: AZN) at the 5th China International Import Expo (CIIE), aimed at enhancing precision whole disease course management services for cancer patients. The collaboration focuses on improving accessibility to novel cancer treatments and other health services, particularly for patients with breast cancer.
Cowell Health’s Business Presence
Cowell Health has a significant business presence across China, covering over 300 cities and including 10,000 chain pharmacies and Direct to Patient (DTP) pharmacies. The company also operates five Internet hospitals. Cowell Health employs a unique professional team model consisting of “One Internet hospital physician + one practice pharmacist + one chronic disease management specialist,” ensuring comprehensive care for patients.
Previous Collaborations
In 2021, Cowell Health, AstraZeneca, and other partners launched a public welfare mini-program for lung cancer patients. This initiative underscores the companies’ commitment to improving patient outcomes and enhancing the accessibility of critical health services.-Fineline Info & Tech
